| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 57.479 | 125.310 | 89.162 | 87.734 | 97.849 | 88.865 |
| Total Income - EUR | - | - | - | - | 57.735 | 134.360 | 90.753 | 92.804 | 102.903 | 92.936 |
| Total Expenses - EUR | - | - | - | - | 56.559 | 132.698 | 89.708 | 139.149 | 113.895 | 111.967 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.176 | 1.662 | 1.045 | -46.345 | -10.992 | -19.031 |
| Net Profit/Loss - EUR | - | - | - | - | 596 | 470 | 154 | -47.273 | -12.021 | -19.031 |
| Employees | - | - | - | - | 5 | 8 | 7 | 7 | 5 | 6 |
Check the financial reports for the company - Astravid Product S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 738 | 5.478 | 9.707 | 3.757 | 8.916 | 6.197 |
| Current Assets | - | - | - | - | 8.637 | 15.474 | 31.301 | 71.494 | 35.983 | 30.351 |
| Inventories | - | - | - | - | 8.175 | 13.591 | 29.031 | 52.514 | 25.229 | 27.074 |
| Receivables | - | - | - | - | 0 | 1.672 | 1.306 | 10.270 | 5.528 | 877 |
| Cash | - | - | - | - | 462 | 211 | 963 | 8.710 | 5.227 | 2.400 |
| Shareholders Funds | - | - | - | - | 639 | 1.096 | 1.225 | -46.044 | -57.926 | -81.257 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.736 | 19.857 | 58.179 | 121.295 | 102.824 | 117.806 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4725 - 4725" | |||||||||
| CAEN Financial Year |
4725
|
|||||||||
Comments - Astravid Product S.r.l.